ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Nephrology

Top Nephrology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WEI SUN MD

Nephrology

37,646

$3.92M

1439
1249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 31%

$104
Average prescription price

Avg: $101

MICHAEL PEREZ M.D.

Nephrology

18,057

$1.03M

637
568 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$57
Average prescription price

Avg: $101

MARIE BENTSIANOV M.D.

Nephrology

18,055

$1.99M

487
407 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 31%

$110
Average prescription price

Avg: $101

STEWART BAE M.D.

Nephrology

12,582

$952K

394
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 31%

$76
Average prescription price

Avg: $101

LAWRENCE CHOY MD

Nephrology

12,264

$767K

403
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$63
Average prescription price

Avg: $101

FRANCIS KENNEDY M.D.

Nephrology

12,098

$733K

238
217 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$61
Average prescription price

Avg: $101

STEVE RUCKER MD

Nephrology

11,029

$1.2M

790
695 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$109
Average prescription price

Avg: $101

BELLA FRIDMAN MD

Nephrology

10,610

$981K

390
340 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 31%

$92
Average prescription price

Avg: $101

MARC SADOVNIC MD

Nephrology

10,230

$690K

475
374 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$67
Average prescription price

Avg: $101

CHRISTOPHER ADUBOR MD

Nephrology

10,200

$710K

512
375 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$70
Average prescription price

Avg: $101

JOSEPH MIHINDUKULASURIYA MD

Nephrology

10,146

$656K

441
335 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 31%

$65
Average prescription price

Avg: $101

LIONEL DESROCHES M.D.

Nephrology

9,772

$914K

547
456 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 31%

$94
Average prescription price

Avg: $101

GEOFFROY PATRICE M.D.

Nephrology

9,031

$445K

267
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$49
Average prescription price

Avg: $101

FARRUQUE AHMED MD

Nephrology

8,470

$464K

690
600 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 31%

$55
Average prescription price

Avg: $101

ROMESH KOHLI MD

Nephrology

8,252

$1.13M

338
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 31%

$137
Average prescription price

Avg: $101

EDWARD LEE M.D.

Nephrology

8,013

$753K

289
247 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 31%

$94
Average prescription price

Avg: $101

JOSEPH BONANNO D.O.

Nephrology

7,975

$452K

388
319 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$57
Average prescription price

Avg: $101

SALIM KHOURY M.D.

Nephrology

7,922

$447K

334
292 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 31%

$56
Average prescription price

Avg: $101

ALLA MASLOVA

Nephrology

7,520

$986K

248
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 31%

$131
Average prescription price

Avg: $101

DANIEL GLICKLICH MD

Nephrology

7,312

$645K

266
90 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 31%

$88
Average prescription price

Avg: $101

RUSSELL CREW MD

Nephrology

7,276

$915K

289
91 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 31%

$126
Average prescription price

Avg: $101

DANG NGUYEN M.D.

Nephrology

7,252

$709K

402
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 31%

$98
Average prescription price

Avg: $101

MICHAEL SCHWARTZMAN MD

Nephrology

6,940

$368K

327
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 31%

$53
Average prescription price

Avg: $101

MARIO HENRIQUEZ MD

Nephrology

6,882

$953K

327
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 31%

$139
Average prescription price

Avg: $101

NAGARAJA SRIDHAR MD

Nephrology

6,652

$716K

462
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 31%

$108
Average prescription price

Avg: $101

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank